/Investor DB

Anaxago

Funding platformoperating company · company profile

Paris · Seed–Series C

Find your way into Anaxago

Sign up to see every warm intro you have to Anaxago

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Anaxago team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Anaxago aims to open up access to rare, impact-oriented investment opportunities previously reserved for large institutional investors. Across real estate crowdfunding, real estate private equity, venture capital, private debt and structured products, the firm emphasizes performance linked to the real economy, transparency through quarterly reporting, and client advisory support. As a mission-driven company since 2023, its purpose is to design, manage and promote opportunities that, beyond financial returns, help reduce and adapt to climate change and support human health. It backs real estate projects and innovative startups/SMEs from seed to Series C.

Source: firm website, verified Nov 1, 2026.

Stage
Seed–Series C
HQ
Paris, FR
Instruments
Equity · Debt
Founded
2012
Tracked investments
7

What they invest in

from 3 of 7 portfolio companies

AgTech ×1Biotech ×1Climate Tech ×1Construction Tech ×1Digital Health ×1FoodTech ×1Medical Devices ×1PropTech ×1

HQs:France×2

Investments · 7 tracked

founders shown can be your intro path
nextProteinnextprotein.coin𝕏✓ verified

nextProtein breeds Black Soldier Fly larvae on unconsumed food to produce insect-based protein, oil and fertilizer used as ingredients in animal feed for aquaculture, poultry, pork and pet food.

AgTechClimate TechFoodTechParis, FR

Syrine Chaalala(Co-founder)inMohamed Gastli(Co-founder)in

Co-investorsKima VenturesAngelorBritish International InvestmentMirovaRAISE

Acticor Biotechacticor-biotech.comin𝕏Nov 2019

Acticor Biotech develops Glenzocimab, a therapeutic candidate targeting GPVI for treating acute ischemic stroke and STEMI.

BiotechDigital HealthMedical Devices

Gilles AVENARD(Chief Executive Officer)

Co-investorsAgoranovCapDecisif ManagementKaristaNewton BiocapitalGO Capital

Greenkubgreenkub.frin

Greenkub designs and builds wooden structures in France — garden studios, home extensions, and full RE2020-compliant timber-frame houses — as turnkey projects prefabricated in its workshops and assembled on the customer's site.

Construction TechPropTechCastries, FR

Co-investorsNewfund Capital

Trust Pilottrustpilot.com

Review platform that IPO'd at a £1bn market cap

Peter Holten Muhlmann(Founder)inAdrian BlairinPeter Holten Mühlmann(Founder)

Co-investors3Comma CapitalBright Pixel CapitalCompanistoDraper AssociatesIndex VenturesMolten Ventures+4 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AgriodorGanymedOsivax

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Anaxago made?
Anaxago has 7 tracked investments.
What stage does Anaxago invest at?
Anaxago invests at the Seed, Series A, Series B, Series C stages.
What sectors does Anaxago focus on?
Anaxago focuses on Climate Tech, Consumer, Fintech, Healthtech, Impact & Social Good, PropTech, Sector Agnostic.
Where is Anaxago located?
Anaxago is headquartered in Paris, FR.
Who does Anaxago co-invest with?
Anaxago most often shares deals with Bright Pixel Capital, Draper Associates, Index Ventures, among 8 tracked co-investors.

Similar investors

Featured in lists